Carregant...
Current status of symptomatic medical therapy in Parkinson’s disease
Symptomatic medical therapies for Parkinson’s disease (PD) have been disease modifying and have led to improvement in daily function, quality of life, and survival. For 40 years, these therapies have been primarily dopaminergic, and currently include the dopamine (DA) precursor levodopa (LD), DA ago...
Guardat en:
| Publicat a: | Neurotherapeutics |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer-Verlag
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084161/ https://ncbi.nlm.nih.gov/pubmed/18394561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2007.12.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|